Activist investor Starboard Value has taken a sizeable stake in Kenvue, the maker of Tylenol and Listerine, and is seeking ...

Activist investor Starboard Value reportedly has taken a large stake in consumer health products maker Kenvue.

Starboard Value, an activist investor, has reportedly acquired a substantial stake in Kenvue Inc, the company behind popular ...

Starboard wants Kenvue, which was spun out of Johnson & Johnson last year and has a market value of over $40 billion, to make ...

While tech-based growth stocks might seem like the right play, you can't ignore dividends if you want to have a strong ...

Liver transplant waitlists can range from 30 days to over five years. Developing treatments that spur liver regeneration could help reduce demand for scarce organs.

When you're on a tight budget, a big box retailer like Walmart can help you save money and stretch your budget. Retirees who ...

Shares of consumer-products company Kenvue Inc.rose the most in more than two months after activist investor Starboard Value took a stake in the Tylenol maker with an eye toward making changes to ...

Kenvue is guiding for $1.10 to $1.20 in 2024 earnings per share and 2% to 4% organic sales growth. If it achieves the ...

Starboard founder and CEO Jeff Smith is expected to discuss the hedge fund's plans for Kenvue at an investor conference tomorrow. Shares of Kenvue (KVUE) took off Monday morning on indications ...

"Zorba Paster On Your Health," now in its 33rd year, airs in more than 20 states and parts of Canada. You can hear it on ...